UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
40 hedge funds and large institutions have $5.87M invested in Unity Biotechnology in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 8 closing their positions.
Holders
40
Holders Change
-2
Holders Change %
-4.76%
% of All Funds
0.58%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
6
Increased
10
Reduced
10
Closed
8
Calls
$71K
Puts
$23K
Net Calls
+$48K
Net Calls Change
-$2.55M
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$175K |
2 |
2
Citadel Advisors
Miami,
Florida
|
$153K |
3 |
3
Millennium Management
New York
|
$61.8K |
4 |
4
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
$29.3K |
5 |
5
Squarepoint
New York
|
$22.9K |